Strathclyde University announces scientists, led by Dr Damion Corrigan, are developing a rapid, low cost and mass manufacturable saliva/nasal swab based biosensor test for COVID-19 inspired by the glucose test strips used to check blood sugar levels in people with diabetes. The electrochemical platform developed by Dr Corrigan’s team can provide a result in 2 minutes. The same platform is ideally suited for rapid, point of care, diagnosis of time sensitive conditions like sepsis and heart attack. These applications are being commercialised by a new spin out company Aureum Diagnostics, backed by Norcliffe Capital.
Read the whole story at https://www.strath.ac.uk/whystrathclyde/news/scientistsdevelopinglowcostsalivabasedcovid-19test/